Kentucky Attorney General announces $75.3 Million settlement in Topamax case - Examiner.com

Examiner.com

Kentucky Attorney General announces $75.3 Million settlement in Topamax case Examiner.com The FDA only approved Topamax for use in treating epileptic seizures and to prevent migraine headaches. Despite these limited approvals, ... Michigan to receive $584000 in settlement of Ortho-McNeil-Jannsen lawsuitExaminer.com all 32 news articles »

Health Risk News 2010: Epilepsy Drugs Get Suicide Risk Warning - Examiner.com

Examiner.com

Health Risk News 2010: Epilepsy Drugs Get Suicide Risk Warning Examiner.com ... used to treat psychiatric disorders, migraines, and other conditions, as well as epilepsy. (MEDICINENET.COM) Those drugs include topiramate (Topamax), ... and more »

Drug Company To Pay Michigan $584K - WHTC

Legal News Line

Drug Company To Pay Michigan $584K WHTC ... to treat things such as bipolar disorder and drug and alcohol dependency. Topamax was approved for treating epileptic symptoms and to prevent migraines. Michigan to get $1.6 million from drug company that promoted off-label uses of ...Crain's Detroit Business Feds settle Topamax whistleblower suitLegal News Line all 26 news articles »

Jefferies Concern About Neuropsychiatric Profile Of Qnexa: VVUS - Benzinga

Jefferies Concern About Neuropsychiatric Profile Of Qnexa: VVUS Benzinga According to Jefferies & Co, “A primary argument in favor of Qnexa is the approval of Topamax for migraine prophylaxis, where the topiramate doses are ... and more »

FDA advisory board to review new diet drug - CNN (blog)

FDA advisory board to review new diet drug CNN (blog) Topiramate, also known as Topamax, is an anticonvulsant used to treat migraines and seizures. In clinical trials, about 45 to 69 percent of Qnexa users lost ... New weight-loss drugs may be on the wayMyFox Tampa Bay FDA Says Obesity Drug Works But With Side EffectsWall Street Journal FDA Review Spurs Confidence in Qnexa Despite Safety IssuesBioWorld Online New York Times (blog) -Minyanville.com -TapeBeat all 980 news articles »

Multiple Sclerosis Market Forecast and Other New Healthcare Equipment ... - MarketWatch (press release)

Multiple Sclerosis Market Forecast and Other New Healthcare Equipment ... MarketWatch (press release) ... the migraine market across the seven major regions was valued at $4.6 billion in 2008. However, following US patent expiries of both Imitrex and Topamax ... and more »